Anxiety treatment in the U.S. has been largely stagnant for a long time and is now about to change rapidly. One such treatment is the use of psychedelics for anxiety, which also includes an LSD, derived compound called MM120. Researchers have reported that this treatment has shown positive results in a Phase 2 trial for generalized anxiety disorder, and the effects have lasted for several weeks following just one dose.
As the use of psychedelics for anxiety becomes popular, the industry is also witnessing the emergence of digital therapeutics and prescription apps that provide a structured cognitive, behavioral intervention through smartphones. A number of evidence, based anxiety treatment apps have recently been launched, leading to high remission rates and thus becoming a resourcedependent option for those unable to attend therapy sessions in person because of cost, location, or long waiting lists.
Medical professionals emphasize that anxiety treatment produces the best results if it is supported by a strong therapeutic relationship, safety monitoring, and taking into account the individual’s values and life circumstances. In spite of the hype around psychedelic anxiety treatment and digital tools, experts caution that issues such as equitable access, appropriate regulation, and integration with existing services must be in place for the innovations to realize their potential.
Leave a Comment